Your browser doesn't support javascript.
loading
Population pharmacokinetic analysis of dutogliptin, a selective dipeptidyl peptidase-4 inhibitor.
Marier, Jean-Francois; Mouksassi, Mohamad-Samer; Gosselin, Nathalie H; Li, Jianke.
Affiliation
  • Marier JF; Pharsight, A Certara Company, Montreal, QC, Canada.
  • Mouksassi MS; Pharsight, A Certara Company, Montreal, QC, Canada.
  • Gosselin NH; Pharsight, A Certara Company, Montreal, QC, Canada.
  • Li J; Phenomix Corporation, San Diego, CA, USA.
Clin Pharmacol Drug Dev ; 3(4): 297-304, 2014 07.
Article in En | MEDLINE | ID: mdl-27128836
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Boronic Acids / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Models, Biological Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Pharmacol Drug Dev Year: 2014 Document type: Article Affiliation country: Canada Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Boronic Acids / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Models, Biological Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Pharmacol Drug Dev Year: 2014 Document type: Article Affiliation country: Canada Country of publication: United States